院長業績（英文）（2021年4月更新）

  1. Sekine Y, Ichimura H, Ueda S, Kobayashi K, Nawa T, Amata A, Chonan T, Sakata A, Komatsu Y, Sato Y. Response to pembrolizumab in a patient with primary lung adenocarcinoma originated from indium lung. BMC Pulm Med. 2021 Mar 31;21(1):107. doi: 10.1186/s12890-021-01474-x. PMID: 33789640; PMCID: PMC8011174.
  2. Omori H, Higashi N, Nawa T, Fukui T, Kaise T, Suzuki T. Associated Factors and Comorbidities of Airflow Limitation in Subjects Undergoing Comprehensive Health Examination in Japan – Survey of Chronic Obstructive Pulmonary Disease Patients Epidemiology in Japan (SCOPE- J). Int J Chron Obstruct Pulmon Dis. 2020 Nov 23;15:3039-3050. doi: 10.2147/COPD.S272588. PMID: 33262583; PMCID: PMC7696619.
  3. A case of ROS1-rearranged lung adenocarcinoma exhibiting pleural effusion caused by crizotinib      Tachi H, Nishino K, Nakaizumi T, Kuramoto K, Shimizu K, Yamamoto Y, Kobayashi K, Ichimura H, Sakata A, Nawa T.   Thorac Cancer. 2020 May 20. doi: 10.1111/1759-7714.13496. Online ahead of print.
  4. Chronic Cough and Phlegm in Subjects Undergoing Comprehensive Health Examination in Japan – Survey of Chronic Obstructive Pulmonary Disease Patients Epidemiology in Japan (SCOPE-J)         Omori H, Higashi N, Nawa T, Fukui T, Kaise T, Suzuki T.       Int J Chron Obstruct Pulmon Dis. 2020 Apr 15;15:765-773. doi: 10.2147/COPD.S237568. eCollection 2020.
  5. Detection of circulating tumor cells in patients with lung cancer using metallic micro-cavity array filter: A pilot study Ichimura H, Nawa T, Yamamoto Y, Shimizu K, Kobayashi K, Kitazawa S, Kanbara H, Odagiri T, Endo K, Matsunaga T, Nakamura S, Yagi S, Sato Y.            Mol Clin Oncol. 2020 Mar;12(3):278-283. doi: 10.3892/mco.2020.1973. Epub 2020 Jan 10.
  6. Real Clinical Practice in ALK-rearranged NSCLC Patients: A Retrospective Observational Study   Okauchi S, Numata T, Nawa T, Ichimura H, Saito T, Hayashihara K, Yamada H, Satoh H, Endo T, Inage Y, Kaburagi T, Kiyoshima M, Yamada Y, Tamura T, Saito K, Inagaki M, Hizawa N, Sato Y, Shiozawa T, Sekine I, Ishikawa H, Kurihima K, Sakai M, Kamiyama K, Kimura M, Kikuchi N, Nakamura H, Furukawa K, Kodama T, Miyazaki K, Yamashita T, Hayashi S, Funayama Y, Nomura A.   Anticancer Res. 2020 Feb;40(2):957-964. doi: 10.21873/anticanres.14029.
  7. A population-based cohort study to evaluate the effectiveness of lung cancer screening using low-dose CT in Hitachi city, Japan Nawa T, Fukui K, Nakayama T, Sagawa M, Nakagawa T, Ichimura H, Mizoue T.      Jpn J Clin Oncol. 2019 Feb 1;49(2):130-136. doi: 10.1093/jjco/hyy185.
  8. Low-dose CT screening for lung cancer reduced lung cancer mortality in Hitachi City       Nawa T. Int J Radiat Biol. 2019 Oct;95(10):1441-1446. doi: 10.1080/09553002.2018.1511930. Epub 2018 Oct 11.
  9. Real Clinical Practice of Using Afatinib Therapy in NSCLC Patients with an Acquired EGFR T790M Mutation           Miyazaki K, Tamura T, Kaburagi T, Saito K, Inagaki M, Yamashita T, Ichimura H, Nawa T, Endo T, Hayashihara K, Kimura M, Kurishima K, Nakamura H, Furukawa K, Kikuchi N, Satoh H, Hizawa N.           Anticancer Res. 2018 Sep;38(9):5409-5415. doi: 10.21873/anticanres.12871.
  10. Acquired EGFR T790M Mutation After Relapse Following EGFR-TKI Therapy: A Population-based Multi-institutional Study          Kaburagi T, Kiyoshima M, Nawa T, Ichimura H, Saito T, Hayashihara K, Yamada H, Satoh H, Endo T, Inage Y, Saito K, Inagaki M, Hizawa N, Sato Y, Ishikawa H, Sakai M, Kamiyama K, Kikuchi N, Nakamura H, Furukawa K, Kodama T, Yamashita T, Nomura A, Yoshida S.      Anticancer Res. 2018 May;38(5):3145-3150. doi: 10.21873/anticanres.12577.
  11. [Outcomes of an Independent Clinical Study to Compare Branded and Generic Formulations of Sustained-Release Oxycodone]   Yamamoto M, Saito Y, Onodera Y, Okawa M, Shimizu K, Yamamoto Y, Nawa T, Aoyama Y.    Gan To Kagaku Ryoho. 2017 Mar;44(3):261-264.
  12. CT Emphysema Constitutes a High Risk for Future Airflow Obstruction　Nawa T, Kusano S, Nakagawa T, Mizoue T, Tachi H, Shimizu K, Yamamoto Y, Hirai S  Ningen Dock International, 2016;3(1): 3-6.
  13. S-1-containing chemotherapy for patients with non-small-cell lung cancer: A population-based observational study by the Ibaraki thoracic integrative (POSITIVE) research group            Inagaki M, Shinohara Y, Kaburagi T, Endo T, Homma S, Hizawa N, Kishi K, Nakamura H, Hayashihara K, Saito T, Kurishima K, Ishikawa H, Ichimura H, Nawa T, Kikuchi N, Miyazaki K, Kodama T, Satoh H, Furukawa K.       Mol Clin Oncol. 2016 Jun;4(6):1025-1030. doi: 10.3892/mco.2016.826. Epub 2016 Mar 21.
  14. Efficacy of first-line erlotinib in non-small cell lung cancer patients undergoing dose reduction and those with a low body surface area: A population-based observational study by the Ibaraki Thoracic Integrative (POSITIVE) Research Group         Inagaki M, Shinohara Y, Kaburagi T, Homma S, Hizawa N, Nakamura H, Hayashihara K, Saito T, Ishikawa H, Ichimura H, Nawa T, Kikuchi N, Miyazaki K, Kodama T, Kamiyama K, Satoh H, Furukawa K. Mol Clin Oncol. 2016 Mar;4(3):425-428. doi: 10.3892/mco.2015.720. Epub 2015 Dec 21.
  15. [A Decrease in Lung Cancer Mortality Following the Implementation of CT Screening for General Population]           Nawa T. Igaku Butsuri. 2015;35(2):158-62.
  16. Low-dose computed tomography screening in Japan           Nawa T, Nakagawa T, Mizoue T, Endo K.     J Thorac Imaging. 2015 Mar;30(2):108-14. doi: 10.1097/RTI.0000000000000138.
  17. Erlotinib for elderly patients with non-small-cell lung cancer: Subset analysis from a population-based observational study by the Ibaraki Thoracic Integrative (POSITIVE) Research Group          Kurishima K, Satoh H, Kaburagi T, Nishimura Y, Shinohara Y, Inagaki M, Endo T, Saito T, Hayashihara K, Hizawa N, Nakamura H, Nawa T, Kagohashi K, Kishi K, Ishikawa H, Ichimura H, Hashimoto T, Sato Y, Sakai M, Kamiyama K, Matsumura T, Unoura K, Fukuoka T, Uchiumi K, Nomura A, Furukawa K.   Mol Clin Oncol. 2013 Sep;1(5):828-832. doi: 10.3892/mco.2013.154. Epub 2013 Jul 23.
  18. Observational study on the efficacy and safety of erlotinib in patients with non-small cell lung cancer           Kaburagi T, Satoh H, Hayashihara K, Endo T, Hizawa N, Kurishima K, Nishimura Y, Hashimoto T, Nakamura H, Kishi K, Inagaki M, Nawa T, Ichimura H, Ishikawa H, Kagohashi K, Fukuoka T, Shinohara Y, Kamiyama K, Sato Y, Sakai M, Matsumura T, Uchiumi K, Furukawa K. Oncol Lett. 2013 Feb;5(2):435-439. doi: 10.3892/ol.2012.1048. Epub 2012 Nov 27.
  19. Bevacizumab-containing chemotherapy for non-small cell lung cancer patients: a population-based observational study by the Ibaraki thoracic integrative (POSITIVE) research group            Nakamura H, Satoh H, Kaburagi T, Nishimura Y, Shinohara Y, Inagaki M, Endo T, Saito T, Hayashihara K, Hizawa N, Kurishima K, Nawa T, Kagohashi K, Kishi K, Ishikawa H, Ichimura H, Hashimoto T, Sato Y, Sakai M, Kamiyama K, Matsumura T, Unoura K, Furukawa K.          Med Oncol. 2012 Dec;29(5):3202-6. doi: 10.1007/s12032-012-0318-5. Epub 2012 Nov 2.
  20. A decrease in lung cancer mortality following the introduction of low-dose chest CT screening in Hitachi, Japan       Nawa T, Nakagawa T, Mizoue T, Kusano S, Chonan T, Hayashihara K, Suito T, Endo K.        Lung Cancer. 2012 Dec;78(3):225-8. doi: 10.1016/j.lungcan.2012.09.012. Epub 2012 Oct 12.
  21. Prevalence of pulmonary arteriovenous malformations as estimated by low-dose thoracic CT screening Nakayama M, Nawa T, Chonan T, Endo K, Morikawa S, Bando M, Wada Y, Shioya T, Sugiyama Y, Fukai S.          Intern Med. 2012;51(13):1677-81. doi: 10.2169/internalmedicine.51.7305. Epub 2012 Jul 1.
  22. Long-term prognosis of patients with lung cancer detected on low-dose chest computed tomography screening            Nawa T, Nakagawa T, Mizoue T, Kusano S, Chonan T, Fukai S, Endo K.      Lung Cancer. 2012 Feb;75(2):197-202. doi: 10.1016/j.lungcan.2011.07.002. Epub 2011 Aug 2.
  23. [A case of angiosarcoma of the scalp with severe fluid retention after administering docetaxel]     Namba R, Kanazawa J, Yamamoto Y, Itou S, Nawa T.  Gan To Kagaku Ryoho. 2011 May;38(5):807-10.
  24. Efficacy of computer-aided diagnosis in lung cancer screening with low-dose spiral computed tomography: receiver operating characteristic analysis of radiologists’ performance Kusano S, Nakagawa T, Aoki T, Nawa T, Nakashima K, Goto Y, Korogi Y.    Jpn J Radiol. 2010 Nov;28(9):649-55. doi: 10.1007/s11604-010-0486-1. Epub 2010 Nov 27.
  25. Efficacy and safety of intravenous peramivir for treatment of seasonal influenza virus infection       Kohno S, Kida H, Mizuguchi M, Shimada J; S-021812 Clinical Study Group.          Antimicrob Agents Chemother. 2010 Nov;54(11):4568-74. doi: 10.1128/AAC.00474-10. Epub 2010 Aug 16.
  26. [A case of postcardiac injury syndrome with repeated pleuritis after blunt chest trauma]        Namba R, Yamamoto Y, Nawa T, Endo K.     Nihon Kokyuki Gakkai Zasshi. 2009 Dec;47(12):1161-5.
  27. A population-based study of gefitinib in patients with non-small cell lung cancer       Hayashibara K, Satoh H, Shinohara Y, Inagaki M, Kaburagi T, Hashimoto T, Kurishima K, Ishikawa H, Ichimura H, Nawa T, Funayama Y, Matsumura T, Kagohashi K, Endo T, Furukawa K, Kishi K, Sumi M, Kamiyama K, Ishikawa S. Med Oncol. 2009;26(2):222-7. doi: 10.1007/s12032-008-9110-y. Epub 2008 Oct 31.
  28. Possible association between heavy computer users and glaucomatous visual field abnormalities: a cross sectional study in Japanese workers  Tatemichi M, Nakano T, Tanaka K, Hayashi T, Nawa T, Miyamoto T, Hiro H, Sugita M.        J Epidemiol Community Health. 2004 Dec;58(12):1021-7. doi: 10.1136/jech.2003.018127.
  29. Laterality of the performance of glaucoma mass screening using frequency-doubling technology    Tatemichi M, Nakano T, Tanaka K, Hayashi T, Nawa T, Iwasaki A, Miyamoto T, Hiro H, Sugita M. J Glaucoma. 2003 Jun;12(3):221-5. doi: 10.1097/00061198-200306000-00007.
  30. Performance of glaucoma mass screening with only a visual field test using frequency-doubling technology perimetry Tatemichi M, Nakano T, Tanaka K, Hayashi T, Nawa T, Miyamoto T, Hiro H, Iwasaki A, Sugita M; Glaucoma Screening Project (GSP) Study Group. Am J Ophthalmol. 2002 Oct;134(4):529-37. doi: 10.1016/s0002-9394(02)01684-7.
  31. [Prevalence of emphysematous changes as shown by low-dose spiral CT screening images in 6144 healthy subjects]             Nawa T, Nakagawa T, Kusano S, Nakata H.       Nihon Kokyuki Gakkai Zasshi. 2002 Jun;40(6):468-72.
  32. Lung cancer screening using low-dose spiral CT: results of baseline and 1-year follow-up studies     Nawa T, Nakagawa T, Kusano S, Kawasaki Y, Sugawara Y, Nakata H.       Chest. 2002 Jul;122(1):15-20. doi: 10.1378/chest.122.1.15.

関連記事

  1. 当院管理栄養士が　ふれあいの郷・金沢　にて講演しました

  2. キッチン陽（はる）のお弁当

  3. 臨時休診のお知らせ（第61回日本肺癌学会学術集会　国際ワーク…

  4. 栄養指導が延べ100例を超えました。

  5. 新型コロナワクチンについて

  6. 診察券番号（ID）：延べ受診者数が10000を超えました

受診のご案内
アクセス
よくあるご質問